An Orthotopic Model of Pancreatic Somatostatin Receptor (SSTR)-Positive Tumors Allows Bimodal Imaging Studies Using 3T MRI and Animal PET-Based Molecular Imaging of SSTR Expression

Publisher： Karger

E-ISSN： 1423-0194|87|4|233-242

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.87, Iss.4, 2007-11, pp. : 233-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radionuclide Therapy via SSTR: Future Aspects from Experimental Animal Studies

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-05 ,pp. : 86-98

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with 111In-Pentetreotide

By  

Neuroendocrinology, Vol. 90, Iss. 2, 2009-08 ,pp. : 184-189

Karger

Access to resources Recommend Favorite

Combination of Cross-Sectional and Molecular Imaging Studies in the Localization of Gastroenteropancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 99, Iss. 2, 2014-01 ,pp. : 63-74

Karger

Access to resources Recommend Favorite

Reassessment of sst3 Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-5

By  

Neuroendocrinology, Vol. 96, Iss. 4, 2012-03 ,pp. : 301-310

Karger

Access to resources Recommend Favorite

Does Somatostatin or Gastric Inhibitory Peptide Receptor Expression Correlate with Tumor Grade and Stage in Gut Neuroendocrine Tumors?

By  

Neuroendocrinology, Vol. 101, Iss. 1, 2015-01 ,pp. : 45-57

Karger

Access to resources Recommend Favorite